Correlation Between First Capital and Transcode Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both First Capital and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining First Capital and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between First Capital and Transcode Therapeutics, you can compare the effects of market volatilities on First Capital and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in First Capital with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of First Capital and Transcode Therapeutics.

Diversification Opportunities for First Capital and Transcode Therapeutics

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between First and Transcode is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding First Capital and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and First Capital is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on First Capital are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of First Capital i.e., First Capital and Transcode Therapeutics go up and down completely randomly.

Pair Corralation between First Capital and Transcode Therapeutics

Given the investment horizon of 90 days First Capital is expected to generate 0.61 times more return on investment than Transcode Therapeutics. However, First Capital is 1.63 times less risky than Transcode Therapeutics. It trades about 0.11 of its potential returns per unit of risk. Transcode Therapeutics is currently generating about 0.02 per unit of risk. If you would invest  4,379  in First Capital on November 10, 2025 and sell it today you would earn a total of  1,041  from holding First Capital or generate 23.77% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy98.39%
ValuesDaily Returns

First Capital  vs.  Transcode Therapeutics

 Performance 
       Timeline  
First Capital 

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in First Capital are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent basic indicators, First Capital reported solid returns over the last few months and may actually be approaching a breakup point.
Transcode Therapeutics 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Transcode Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Transcode Therapeutics may actually be approaching a critical reversion point that can send shares even higher in March 2026.

First Capital and Transcode Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with First Capital and Transcode Therapeutics

The main advantage of trading using opposite First Capital and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if First Capital position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.
The idea behind First Capital and Transcode Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Transaction History
View history of all your transactions and understand their impact on performance
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device